SCHEMBL8960305

SCHEMBL8960305

CCCCCCC(=O)C(OP(=O)([O-])OCC[N+](C)(C)C)[C@@H](O)CO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.54
ESR1 P03372 1/20 0.54
ADORA3 P0DMS8 1/20 0.54
CDC25A P30304 1/20 0.54
AGTR1 P30556 1/20 0.54
AKT1 P31749 1/20 0.54
ADRA1A P35348 1/20 0.54
KCNH2 Q12809 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.52
PLA2G1B P04054 1/20 0.52
PLA2G2A P14555 1/20 0.52
NR5A2 O00482 1/20 0.52
NR5A1 Q13285 1/20 0.52
MAPT P10636 3/20 0.50
PLA2G10 O15496 1/20 0.50
MAPK1 P28482 4/20 0.49
MEN1 O00255 2/20 0.49
GMNN O75496 2/20 0.49
BLM P54132 2/20 0.49
KMT2A Q03164 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6268031 1.00 LMNA (0.54) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL1648522 1.00 LMNA (0.54) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL2370673 1.00 LMNA (0.54) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL15566127 1.00 LMNA (0.54) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL5251441 1.00 LMNA (0.54) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL9073605 1.00 LMNA (0.54) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL6384775 0.94 MEN1 (0.53) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL7515687 0.94 PLA2G1B (0.49) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL9005240 0.92 LMNA (0.46) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL18554720 0.92 LMNA (0.46) LMNAESR1ADORA3CDC25AAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996040694-A1 CARBONOTHIOATE PHOSPHOLIPID ANALOGS AS SUBSTRATE OF PHOSPHOLIPASES AND LIPASES LA JOLLA PHARMACEUTICAL COMPANY (US) 1996-12-19 WO disclosed
EP-0691852-A1 PRODRUGS WITH ENHANCED PENETRATION INTO CELLS D-PHARM, LTD. (IL) 1996-01-17 EP disclosed
WO-1994022483-A2 PRODRUGS WITH ENHANCED PENETRATION INTO CELLS D-PHARM, LTD. (IL) 1994-10-13 WO disclosed